NAS:MASI (USA) Also Trade In: Germany Mexico UK

Masimo Corp $ 250.73 4.62 (1.88%)

Avg Vol (1m):
Market Cap $:
13.86 Bil
Enterprise Value $:
13.25 Bil
PE Ratio:
PB Ratio:
Warning! GuruFocus has detected 1 Severe warning sign with MASI. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

MASI News and Headlines - Masimo Corp

GuruFocus Articles Total 31
  • 1
  • 2

2020 was one of the most interesting years in our career. It turns out the best thing to do - as with almost any other year - was to stand pat

January 2021

To Our Officers and Investors:

Enclosed you will find our report on the 2020 performance of the Nintai Investments LLC Composite Portfolio managed by Nintai Investments LLC. Returns reflect performance since October 31, 2017 when the company began operations.

2020 returns

Overall, we were quite pleased with the Nintai model portfolio which is used as the basis for investment selection and asset allocation. At year-end, Nintai Investments LLC had $12,610,600 in assets under management (AUM). At the beginning of 2020, the company had $6,411,300 in AUM.

Our 2020 performance surpassed all three major indexes which we track. The

1438 Views    Thomas Macpherson    2021-01-28 19:44
Edwards Lifesciences, Franco-Nevada and Masimo emerge from the Profitable Predictable Margin Expanders screener

There are many useful nooks and crannies on the GuruFocus website, including screeners that help us find stocks outside the mainstream.

For example, consider the Profitable Predictable Margin Expanders screener. No description of this preset screener is provided, but we can safely divine its meaning from the name. We can also glean the details by studying its column headings:

  • Financial strength rating of at least 8 out of 10.
  • Profitability rating of at least 8 out of 10.
  • Predictability rating of at least 3 out of 5.
  • Net margin of at least 10%.
  • Five-year operating margin growth rate
342 Views    Robert Abbott    2020-11-05 20:36
GuruFocus Screener feature highlights effective filters

According to the All-in-One Screener, a Premium feature of GuruFocus, five stalwarts that have high financial strength and expanding operating margins include Mastech Digital Inc. (MHH), Columbia Sportswear Co. (COLM), Medifast Inc. (MED), Masimo Corp. (MASI) and Edwards Lifesciences Corp. (EW).

What is a stalwart?

Peter Lynch, the legendary Fidelity Magellan Fund manager, defined a stalwart as a large, well-established company that still offers growth potential. According to the Stalwarts screen, key criteria include good business predictability, high returns on invested capital and 10-year revenue and earnings growth rates between 10% and

511 Views    James Li    2020-10-06 21:39
New Historical Data Screen identifies stocks with high returns over the past 5 years

According to the Historical Data Screen, a new screening capability for GuruFocus Premium Plus members, four high-quality stocks that had strong returns on equity over the past five years and low Greenblatt earnings yields are Apple Inc. (AAPL), Copart Inc. (CPRT), Exponent Inc. (EXPO) and Masimo Corp. (MASI).

Historical Data Screen feature helps finding good stocks

GuruFocus' High-Quality Screen selects stocks with high financial strength, profitability and business predictability. One characteristic of high-quality stocks is a 10-year median return on equity of at least 15%.

The Historical Data Screen feature allows us

858 Views    James Li    2020-09-28 21:35
Doing well by doing good

California-based Masimo (MASI) is a leading medical technology company focused on the non-invasive patient monitoring niche. The mid-cap company is widely recognized for being one of the most innovative companies in the medical device industry and is most well-known for the signal extraction technology (referred to as “SET”) that it invented. With Masimo SET, hospitals can significantly reduce false alarms by as much as 95%, thereby improving healthcare outcomes and cutting wastes in operational costs.

Masimo was founded by Joe Kiani, an American entrepreneur immigrated from Iran, who currently still holds the positions of Chairman and CEO of the company

447 Views    Steven Chen    2020-04-01 15:45
Stocks to consider as markets wobble on stimulus bill uncertainty

In light of the markets fluctuating between the intraday high and intraday low, four stocks with high profitability and business predictability are Franco-Nevada Corp. (FNV), Grand Canyon Education Inc. (LOPE), Masimo Corp. (MASI) and Nvidia Corp. (NVDA) according to the Profitable Predictable Margin Expanders Screen, a Premium screener within our All-in-One Screener.

Dow fluctuates between intraday high and intraday low on Senate stimulus bill uncertainty

On Wednesday, the Dow Jones Industrial Average closed at 21,187.29, up 495.64 points or 2.39% from Tuesday’s close of 20,704.91. Despite this, the 30-stock index traded between an intraday

786 Views    James Li    2020-03-25 21:20
Stocks to consider as China agrees to purchase $200 billion in US goods, including pharma

According to the All-in-One Screener, a GuruFocus Premium feature, four health care companies with high financial strength and profitability are Biogen Inc. (BIIB), Illumina Inc. (ILMN), Masimo Corp. (MASI) and Novo Nordisk A/S (NVO).

China agrees to purchase $200 billion worth of U.S. goods as part of trade deal, including pharma products

On Wednesday, Chinese President Xi Jinping and U.S. President Trump signed “phase one” of their landmark trade deal, which includes China purchasing $200 billion in U.S. goods over the next two years. Manufactured goods, which include industrial equipment, electric equipment and pharmaceutical products, account

585 Views    James Li    2020-01-15 22:50
Bausch Health Companies tops the list

According to the GuruFocus All-In-One Screener as of Tuesday, the following health care stocks are popular among gurus.

Masimo Corp. (MASI) is held by six gurus

The Irvine, California-based medical device company has a market cap of $7.63 billion. Its revenue of $895 million has risen 11.90% over a 10-year period.


The stock is trading with a price-book ratio of 7.50. The share price of $149 is 8.51% below the 52-week high and 49.25% above the 52-week low. Over the last 10 years, it has returned 461.29%.

The company’s largest guru shareholder is

172 Views    Tiziano Frateschi    2019-10-01 18:50
Stocks have high operating margin growth and are profitable over the past 10 years

According to the Good Companies Screen, a predefined screen within our All-in-One Guru Screener, five stocks that have high operating margin growth and have been profitable over the past 10 years are Masimo Corp. (MASI), Nathan’s Famous Inc. (NATH), Edwards Lifesciences Corp. (EW), Chemed Corp. (CHE) and The Toro Co. (TTC).

Dow snaps eight-day winning streak

On Monday, the Dow Jones Industrial Average closed at 27,076.82, down 142.70 points from last Friday’s close of 27,219.52. The Dow closed lower for the first time since Sept. 3 on the heels of increased economic slowdown fears due to crude oil

509 Views    James Li    2019-09-16 21:52
In these days of wild market fluctuations, revisiting your portfolio through the dual lenses of circles of competence and comfort can be quite helpful

As a long-time value investor, I’ve grown up with the first principle that market downturns allow you to buy more of the stocks you love the most. Who can forget Warren Buffett (Trades, Portfolio)’s classic analogy about buying steak or hamburger on sale? But like many of those things that are good for you in theory but truly wretched in practice (prune juice, 5:30 a.m. exercise routines or the dreaded tetanus shot), watching the prices of your investment partners’ assets take some dizzying drops really isn’t a lot of fun. In theory, watching iRadimed

133 Views    Thomas Macpherson    2019-08-07 17:01
Right after discussing the importance of industry knowledge, I show my hypocrisy by introducing this investment research approach

I think a great capital allocator will intuitively understand that there really isn’t anything he or she can do to improve long-term returns. Most of the time they understand the decision to partner with a particular management team is the most fruitful action of the entire relationship.”

- Bill Bishop

Don't gamble; take all your savings and buy some good stock and hold it till it goes up, then sell it. If it don't go up, don't buy it.”

- Will Rogers

There’s much be said for both Bishop’s and Roger’s thinking – though I think good old

326 Views    Thomas Macpherson    2019-07-22 15:30
Having a focused portfolio has both its advantages and disadvantages. While small in numbers, research on each company holding is extensive.

The writer Ernest Hemingway was having lunch with friends when he was bet by them that he couldn’t write an entire story in just six words. When you think about it, it does sound impossible – how do you get around the requirements of character introduction, plot development, character relationships, etc.? Hemingway quickly took the bet and scratched his story on a cocktail napkin. He passed around the following:


What a remarkable effort. Utilizing six words, he told a story that has so many possibilities and an infinite amount of beginnings and endings. His

686 Views    Thomas Macpherson    2019-04-28 15:01
Dallas-based vehicle auctioneer tops list of stalwarts in terms of operating margin

According to the All-in-One Screener, five Peter Lynch stalwarts with strong profit margins are Copart Inc. (CPRT), Intel Corp. (INTC), Edwards Lifesciences Corp. (EW), Masimo Corp. (MASI) and IDEXX Laboratories Inc. (IDXX).

Starting point: Peter Lynch Stalwarts screen

According to Investopedia, Lynch defined a stalwart as “a large, well-established company that still offers long-term growth potential.” The investor sought companies with a strong balance sheet, little or no debt, solid cash flow and earnings growth between 10% and 12%.

GuruFocus launched a new version of the All-in-One Screener

774 Views    James Li    2019-04-26 20:47
Lulemon tops the list

According to the GuruFocus All-in-One Guru Screener, the following stocks have outperformed the Standard & Poor's 500 index over the past 12 months and were bought by gurus during the last quarter.

Lululemon Athletica Inc. (LULU) has a market cap of $18.19 billion. It has outperformed the S&P 500 index by 107.5% over the past 12 months.


The stock is trading with a price-earnings ratio of 53.48. According to the DCF calculator, the stock is overpriced by 88% at $137 per share. The stock price is currently 129.32% above its 52-week low and 16.60%

321 Views    Tiziano Frateschi    2018-10-24 19:47
Masimo fills a specific need and does it well

I am sure most of you have been to a doctor in the last year. Likely, your blood oxygen levels were tested using a pulse oximeter. It’s an easy process and goes on your finger, testing your pulse, but also blood oxygen. Masimo likely made it. The Masimo Corp. (NASDAQ: MASI) is a leading niche manufacturer in the medical industry specializing in its signature product, the pulse oximeter. The kick is that it allows doctors to test a patient’s blood oxygen level in a completely non-invasive way.

We see Masimo with its solid upward growth prospects as a

295 Views    John Engle    2018-09-04 15:41
Health care-focused fund releases 2nd-quarter portfolio

The Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) disclosed seven new positions when it released its second-quarter portfolio this week.

Managed by Jason Kritzer and Samantha Pandolfi, the fund invests heavily in the health care space. The portfolio managers search around the world for securities that are not only reasonably priced, but which they believe will grow in value over time.

The five largest new positions the fund established during the quarter were GlaxoSmithKline PLC (LSE:GSK), Novartis AG (NVS), Lonza Group Ltd. (XSWX:LONN), Medtronic PLC (MDT) and Masimo Corp. (MASI).


The fund invested in 1.3

123 Views    Sydnee Gatewood    2018-08-02 18:22
Rising interest rates can offset corporate growth when it comes to corporate valuations

“In the field of monetary and credit policy, precautionary action to prevent inflationary excesses is bound to have some onerous effects--if it did not it would be ineffective and futile. Those who have the task of making such policy don’t expect you to applaud. The Federal Reserve, as one writer put it, after the recent increase in the discount rate, is in the position of the chaperone who has ordered the punch bowl removed just when the party was really warming up."[1]

- William McChesney Martin

Early in his career, a well-known behaviorist was watching students coming to class

485 Views    Thomas Macpherson    2018-06-28 19:55
Lincoln National tops the list

According to the GuruFocus All-In-One Screener, the following companies have grown their revenues and earnings over the past several years.

Lincoln National Corp(LNC) has a five-year annual revenue growth rate of 11% and a five-year annual earnings per share (EPS) growth rate of 33%. The stock is trading with a price-earnings (P/E) ratio of 13.1 and has a positive six-month return of 20.4%.


The insurance company has a market cap of $18.46 billion and an enterprise value of $21.85 billion.

GuruFocus gives the company a profitability and growth rating of 6 out of

256 Views    Tiziano Frateschi    2018-01-17 20:42
DaVita, Masimo among companies with falling stock prices and returns

While gurus hold positions in these companies, the stock prices and returns continue to fall. These are the worst-performing stocks over the past three months with a long-term presence in more than four gurus’ portfolios.

Treehouse Foods Inc. (THS) had a negative performance of 24.6% over the last six months. The stock has a total weight of 1.69% on gurus’ portfolios.

The company has a market cap of $3.86 billion. The stock is trading with a price-sales (P/S) ratio of 0.60. The price of $67.58 is 25.26% below its 52-week high and 7.89% above its 52-week low. Over

87 Views    Tiziano Frateschi    2017-10-24 16:12
Investor's largest 1st-quarter sales

John Hussman (Trades, Portfolio) manages a portfolio composed of 194 stocks with a total value of $452 million. During the first quarter, the guru sold shares of the following stocks.

The investor closed his position in Medtronic PLCÂ (MDT) with an impact of -1.77% on the portfolio.

The company is engaged in providing medical technology alleviating pain, restoring health and extending lives. It currently functions in four operating segments that manufacture and sell device-based medical therapies.

GuruFocus gives the stock a profitability and growth rating of 8 out of 10. The return on equity (ROE) of

209 Views    Tiziano Frateschi    2017-05-04 19:43

Headlines Total 118
  • 1
  • 2

2021-02-24 $ 251.2 (1.2%)
2021-02-23 $ 248.22 (-0.72%)
2021-02-22 $ 250.02 (-3.6%)
2021-02-17 $ 267.38 (-2.24%)
2021-02-11 $ 270.79 (1.47%)
2021-02-05 $ 260.29 (1.43%)
2021-01-20 $ 263.53 (0.97%)
2021-01-15 $ 261.37 (-0.15%)
2021-01-14 $ 261.76 (-5.25%)
2021-01-12 $ 279.92 (-1.35%)
2020-12-24 $ 265.94 (0.17%)
2020-12-17 $ 267.72 (1.13%)
2020-12-14 $ 263 (-0.75%)
2020-12-10 $ 270.45 (0.96%)
2020-12-07 $ 267.53 (0.86%)
2020-11-14 $ 245.54 (-0.37%)
2020-11-12 $ 246.46 (0.67%)
2020-11-02 $ 225.36 (0.69%)
2020-10-29 $ 225.68 (-3.39%)
2020-10-28 $ 233.6 (-7%)
2020-10-27 $ 251.18 (2.09%)
2020-10-26 $ 246.04 (0.52%)
2020-10-22 $ 239.66 (2.35%)
2020-10-21 $ 234.16 (-0.92%)
2020-10-20 $ 236.33 (0.25%)
2020-10-14 $ 231.89 (-0.37%)
2020-10-13 $ 232.76 (-0.01%)
2020-10-09 $ 242.43 (0.57%)
2020-10-08 $ 241.06 (-1.9%)
2020-10-02 $ 234.25 (-0.93%)
2020-09-01 $ 223.65 (-0.16%)
2020-08-27 $ 219.89 (0.76%)
2020-08-21 $ 219.19 (-1.71%)
2020-08-18 $ 218.89 (-0.53%)
2020-08-17 $ 220.05 (2.78%)
2020-07-29 $ 218.77 (-7.04%)
2020-07-28 $ 235.35 (-0.15%)
2020-07-21 $ 245.25 (-0.63%)
2020-07-15 $ 229.75 (2.41%)
2020-07-13 $ 220.53 (-4.59%)
2020-07-06 $ 234.6 (1.24%)
2020-07-01 $ 229.7 (0.75%)
2020-06-29 $ 219.73 (1.03%)
2020-06-26 $ 217.5 (-1.38%)
2020-06-24 $ 222.07 (-2.69%)
2020-06-22 $ 229.03 (1.33%)
2020-06-19 $ 226.03 (2.09%)
2020-06-18 $ 221.41 (-1.51%)
2020-06-09 $ 215.78 (0.62%)
2020-06-05 $ 220.24 (0.75%)
2020-05-28 $ 234.36 (4.51%)
2020-05-18 $ 246.82 (-0.8%)
2020-05-11 $ 250.39 (5.59%)
2020-04-29 $ 212.95 (0.18%)
2020-04-28 $ 212.56 (-0.83%)
2020-04-27 $ 214.33 (3.01%)
2020-04-24 $ 208.07 (1.97%)
2020-04-21 $ 197.24 (-0.51%)
2020-04-20 $ 198.25 (-0.73%)
2020-04-17 $ 199.7 (-2.6%)
2020-04-16 $ 205.03 (2.19%)
2020-04-15 $ 200.63 (4.11%)
2020-04-14 $ 192.71 (5.39%)
2020-04-13 $ 182.86 (-1.38%)
2020-04-09 $ 185.42 (0.13%)
2020-04-08 $ 185.18 (1.05%)
2020-04-07 $ 183.26 (-1.01%)
2020-04-06 $ 185.13 (1.65%)
2020-04-03 $ 182.12 (-0.92%)
2020-04-01 $ 178.49 (0.77%)
2020-03-30 $ 179.76 (0.41%)
2020-03-16 $ 174.19 (-6.74%)
2020-02-06 $ 175.4 (0.07%)
2020-01-18 $ 169.74 (-0.05%)
Total 118
  • 1
  • 2